Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-002649-19Phase 4Completed
Phase 4, single-arm trial of escitalopram in panic disorder, sponsored by Tartu University Hospital. Primary endpoints: Treatment response by Panic Disorder Severity Scale, Clinical severity by Panic Disorder Severity Scale and 2 more. Started Dec 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-002649-19.